Faricimab Effectively Resolves Intraretinal Fluid and Preserves Vision in Refractory, Recalcitrant, and Nonresponsive Neovascular Age-Related Macular Degeneration.

Cheng, Anny M; Joshi, Sunir; Banoub, Raphael G; Saddemi, Jackson; Chalam, Kakarla V

Cheng, Anny M; Joshi, Sunir; Banoub, Raphael G; Saddemi, Jackson; Chalam, Kakarla V.

Afiliación

Cheng AM; Ophthalmology, Broward Health, Fort Lauerdale, USA.
Joshi S; Ophthalmology, Specialty Retina Center, Coral Springs, USA.
Banoub RG; Ophthalmology, Florida International University, Herbert Wertheim College of Medicine, Miami, USA.
Saddemi J; Ophthalmology, South Florida Vision, Fort Lauerdale, USA.
Chalam KV; Ophthalmology, Broward Health, Fort Lauerdale, USA.

Cureus ; 15(6): e40100, 2023 Jun.

Article en En | MEDLINE | ID: mdl-37425528

Palabras clave

central subfield thickness; faricimab; intraretinal fluid; intravitreal anti-vascular endothelial growth factor; refractory namd; subretinal fluid; vabysmo

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google